Biologic Therapies Targeting Eosinophilic Gastrointestinal Diseases
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
How should we interpret the data of eosinophilic esophagitis patients from an academic institution?.
Oshima T JGH Open. 2023; 7(8):525-526.
PMID: 37649857 PMC: 10463014. DOI: 10.1002/jgh3.12962.
References
1.
Chen J, Oshima T, Huang X, Tomita T, Fukui H, Miwa H
. Esophageal Mucosal Permeability as a Surrogate Measure of Cure in Eosinophilic Esophagitis. J Clin Med. 2022; 11(14).
PMC: 9319696.
DOI: 10.3390/jcm11144246.
View
2.
Lipka S, Kumar A, Miladinovic B, Richter J
. Systematic review with network meta-analysis: comparative effectiveness of topical steroids vs. PPIs for the treatment of the spectrum of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2016; 43(6):663-73.
DOI: 10.1111/apt.13537.
View
3.
Pesek R, Reed C, Collins M, Muir A, Fulkerson P, Menard-Katcher C
. Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders. Dig Dis Sci. 2019; 65(7):2024-2035.
PMC: 7315780.
DOI: 10.1007/s10620-019-05961-4.
View
4.
Dellon E, Gonsalves N, Abonia J, Alexander J, Arva N, Atkins D
. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. 2022; 20(11):2474-2484.e3.
PMC: 9378753.
DOI: 10.1016/j.cgh.2022.02.017.
View
5.
Pitlick M, Li J, Pongdee T
. Current and emerging biologic therapies targeting eosinophilic disorders. World Allergy Organ J. 2022; 15(8):100676.
PMC: 9356173.
DOI: 10.1016/j.waojou.2022.100676.
View